| Year |
Citation |
Score |
| 2012 |
Venkatachalan SP, Czajkowski C. Structural link between γ-aminobutyric acid type A (GABAA) receptor agonist binding site and inner β-sheet governs channel activation and allosteric drug modulation. The Journal of Biological Chemistry. 287: 6714-24. PMID 22219195 DOI: 10.1074/Jbc.M111.316836 |
0.603 |
|
| 2009 |
Butts CA, Xi J, Brannigan G, Saad AA, Venkatachalan SP, Pearce RA, Klein ML, Eckenhoff RG, Dmochowski IJ. Identification of a fluorescent general anesthetic, 1-aminoanthracene. Proceedings of the National Academy of Sciences of the United States of America. 106: 6501-6. PMID 19346473 DOI: 10.1073/Pnas.0810590106 |
0.544 |
|
| 2008 |
Venkatachalan SP, Czajkowski C. A conserved salt bridge critical for GABA(A) receptor function and loop C dynamics. Proceedings of the National Academy of Sciences of the United States of America. 105: 13604-9. PMID 18757734 DOI: 10.1073/Pnas.0801854105 |
0.598 |
|
| 2007 |
Venkatachalan SP, Bushman JD, Mercado JL, Sancar F, Christopherson KR, Boileau AJ. Optimized expression vector for ion channel studies in Xenopus oocytes and mammalian cells using alfalfa mosaic virus. Pflã¼Gers Archiv : European Journal of Physiology. 454: 155-63. PMID 17146677 DOI: 10.1007/S00424-006-0183-1 |
0.416 |
|
| 2002 |
Venkataraman P, Venkatachalan SP, Joshi PR, Muthalagi M, Schulte MK. Identification of critical residues in loop E in the 5-HT3ASR binding site. Bmc Biochemistry. 3: 15. PMID 12079500 DOI: 10.1186/1471-2091-3-15 |
0.306 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2002 |
Venkataraman P, Joshi P, Venkatachalan SP, Muthalagi M, Parihar HS, Kirschbaum KS, Schulte MK. Functional group interactions of a 5-HT3R antagonist. Bmc Biochemistry. 3: 16. PMID 12079499 DOI: 10.1186/1471-2091-3-16 |
0.22 |
|
| 2004 |
Zhang Y, Venkatachalan SP, Xu H, Xu X, Joshi P, Ji HF, Schulte M. Micromechanical measurement of membrane receptor binding for label-free drug discovery. Biosensors & Bioelectronics. 19: 1473-8. PMID 15093219 DOI: 10.1016/J.Bios.2003.12.011 |
0.213 |
|
| 2021 |
Shekdar K, Langer J, Venkatachalan S, Schmid L, Anobile J, Shah P, Lancaster A, Babich O, Dedova O, Sawchuk D. Cell engineering method using fluorogenic oligonucleotide signaling probes and flow cytometry. Biotechnology Letters. PMID 33683511 DOI: 10.1007/s10529-021-03101-5 |
0.162 |
|
| 2022 |
Daniels MH, Malojcic G, Clugston SL, Williams B, Coeffet-Le Gal M, Pan-Zhou XR, Venkatachalan S, Harmange JC, Ledeboer M. Discovery and Optimization of Highly Selective Inhibitors of CDK5. Journal of Medicinal Chemistry. PMID 35143203 DOI: 10.1021/acs.jmedchem.1c02069 |
0.069 |
|
| 2022 |
Westerling-Bui AD, Fast EM, Soare TW, Venkatachalan S, DeRan M, Fanelli AB, Kyrychenko S, Hoang H, Corriea GM, Zhang W, Yu M, Daniels M, Malojcic G, Pan-Zhou XR, Ledeboer MW, et al. Transplanted organoids empower human preclinical assessment of drug candidate for the clinic. Science Advances. 8: eabj5633. PMID 35857479 DOI: 10.1126/sciadv.abj5633 |
0.054 |
|
| 2015 |
Garyantes T, Wang-Fischer y, Luo R, Babich O, Venkatachalan S, Gutierrez J, Shah K. (409) Chromocell's Compounds A: a novel, orally active, selective NaV1.7 inhibitor The Journal of Pain. 16: S78. DOI: 10.1016/j.jpain.2015.01.328 |
0.047 |
|
| Hide low-probability matches. |